PHLDA1 and metabolic dysfunction-associated steatotic liver disease: We report here that TDAG51 is reduced in several distinct liver injury models and that restoring hepatic TDAG51 levels rescues the underlying IR and NAFLD in diet- and genetic-induced mouse models of fatty liver disease.